Stocks股票 / Health Care / CPRX
Catalyst Pharmaceuticals Partners, Inc. · Health Care
CPRX US listed · USD美股 · 美元
Mid cap中盘 · $4B
Secular growth长期成长
Health Care
S&P 600标普600小盘
$31.49
+$0.00 · +0.00%
52w low52周低 $18.82high高 $31.78
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Stretched/late — protect gains and don't start new positions; let the next low set up first.已拉伸／晚期——保护利润，不要新开仓；先等下一个低点构筑成形。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
70
Overbought超买区域
vs 50-day average相对50日均线
+0.5% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+23.3% above上方
Long trend up长期向上
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0516days to go天后公布
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | CPRX | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 18.00x | 28.59 | |
| P/B市净率 | 4.04x | 3.44 | |
| P/S市销率 | 6.55x | 2.97 | |
| Earnings yield盈利收益率 | 5.56% | 2.72 | |
| FCF yield自由现金流收益率 | 5.41% | 4.00 | |
| Shareholder yield股东收益率 | 0.66% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 12.20x | 18.18 | |
| P/FCF市值/自由现金流 | 18.49x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 37.7%
Earnings per share每股收益
5-yr growth5年复合增速 18.8%
Free cash flow自由现金流
Operating margin营业利润率
43.8%
Net margin净利率
36.4%
FCF margin自由现金流利润率
35.4%
Balance-sheet quality财务体质 4/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 22%
Watch关注
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-2.75
Current ratio流动比率6.08
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$25.3M
Stock-based comp股权薪酬$24.8M
Share count change (1y)股数变化（1年）+1.4%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
CPRX StochRSI turned up from oversoldCPRX StochRSI自超卖区上行
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$1.8M net (0 buyers, 3 sellers)-$1.8M 净值（0 买家，3 卖家）
Signal history信号历史
engine events引擎事件
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS. Late in the daily cycle (day 82 of ~23-44) — odds favor a dip into the next cycle low from here even with the trend intact. Last cycle was left-translated (topped early) — a bearish structural tell止盈。处于日线周期晚期（约 23-44 天中的第 82 天）——即便趋势完好，从此处概率上仍倾向于回落至下一个周期低点。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Jul 17, 2026
CPRX StochRSI turned up from oversoldCPRX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $31.49.StochRSI重回20上方 — 下行动量趋缓的最早预警。$31.49。
Jul 14, 2026
CPRX RSI reached overboughtCPRX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $31.49.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$31.49。
Jul 6, 2026
CPRX made a new 52-week highCPRX 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $31.50.价格创出52周新高 — 全市场关注的动量/趋势极值。$31.50。
Jul 6, 2026
CPRX StochRSI turned up from oversoldCPRX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $31.50.StochRSI重回20上方 — 下行动量趋缓的最早预警。$31.50。
Jul 2, 2026
CPRX RSI reached overboughtCPRX RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $31.45.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$31.45。
Jun 24, 2026
CPRX StochRSI turned up from oversoldCPRX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $31.42.StochRSI重回20上方 — 下行动量趋缓的最早预警。$31.42。
Jun 23, 2026
CPRX took relative-strength leadershipCPRX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $31.40.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$31.40。
Jun 17, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Jun 17, 2026
CPRX took relative-strength leadershipCPRX 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $31.40.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$31.40。
Showing the last 15 of显示最近15条，共 230 signals条信号
Company profile公司档案
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
- Receivables stretch
- Inventory build
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 18.0× | 28.6× | 79% |
| Price / Book市净率 | 4.0× | 3.4× | 41% |
| Price / Sales市销率 | 6.5× | 3.0× | 19% |
| EV / EBITDAEV/EBITDA | 12.2× | 18.2× | 81% |
| Earnings yield盈利收益率 | 5.6% | 2.7% | 85% |
| Free-cash-flow yield自由现金流收益率 | 5.4% | 5.5% | 48% |
| Shareholder yield股东综合回报率 | 0.7% | 1.9% | 27% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
66/100 — middle of the pack居中
vs market, 3 months相对大盘（3个月）
80/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
84/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
76/100 — stronger than most强于多数
Rank in sector行业内排名
#54 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.1% | -1.5% |
| 1 Month近1月 | +0.3% | +0.6% |
| 3 Months近3月 | +19.9% | +4.7% |
| 6 Months近6月 | +38.7% | +7.8% |
| Year to date年初至今 | +36.0% | +9.1% |
| 1 Year近1年 | +46.8% | +19.4% |
| 3 Years近3年 | +126.7% | +69.4% |
Trading information交易信息
Beta vs market贝塔
0.64
Short interest空头占比
6.4% of float
Market cap市值
$4B
EPS (trailing)每股收益
$1.75
Off 52-week high距52周高点
-0.0%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $119M | $141M | $214M | $398M | $492M | $589M |
| EPS每股收益 | $0.71 | $0.37 | $0.75 | $0.63 | $1.31 | $1.68 |
| Free cash flow自由现金流 | $45M | $59M | $116M | $143M | $239M | $209M |
| Gross margin毛利率 | 85.7% | 84.5% | 83.9% | 86.9% | 86.0% | 85.2% |
| Net margin净利率 | 63.0% | 28.0% | 38.8% | 17.9% | 33.3% | 36.4% |
| FCF margin自由现金流利润率 | 37.8% | 42.1% | 54.2% | 36.0% | 48.7% | 35.4% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$589M
Net income净利润
$214M
Operating cash flow经营现金流
$209M
Total assets总资产
$1.1B
Shareholder equity股东权益
$954M
Buybacks股票回购
$25M
Shares outstanding总股本
0.12B
Returns & growth回报与增长
Return on equity股本回报率
22.5%
Return on assets资产回报率
19.4%
Profit growth利润增速
+30.8%
Asset growth资产增速
+29.7%
Accounting quality checks会计质量检查
- Earnings quality: accruals elevated vs peers (earnings lean on non-cash items)盈利质量：应计利润高于同业（盈利依赖非现金项目）
- Working capital: inventory +699% vs sales +395%; receivables +2012% vs sales +395% — demand & revenue-quality risk营运资本：存货 +699% 对销售 +395%；应收 +2012% 对销售 +395%——需求与营收质量风险
- Pricing power: gross margin −0.5pts over 6 years定价能力：毛利率 6 年下降 0.5 个百分点
- Capital discipline: share count +18.0% over 6 years (dilution)资本纪律：股本 6 年增加 18.0%（稀释）
- Balance sheet: Altman Z 18.18 — safe zone资产负债表：Altman Z 18.18——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
70
RSI (2-day)RSI（2日）
91
vs 20-day average相对20日均线
+0.1%
vs 50-day average相对50日均线
+0.5%
vs 200-day average相对200日均线
+23.3%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down动能向下
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
CoiledCOILED
Days compressed已压缩天数
33
Range width percentile波幅宽度分位
0/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
1
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+2.1%
Net upgrades, 30 days净上调（30天）
+1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$1.8M
Insider buyers vs sellers内部人买家vs卖家
0 : 3
Short interest空头占流通盘
6.4%
Days to cover回补天数
3.3
Short interest change空头变化
-1.3%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Mar · 100%
Weakest month最弱月份
Sep · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 67% | +4.4% | 3 |
| Feb2月 | 67% | +1.9% | 3 |
| Mar3月 | 100% | +6.5% | 3 |
| Apr4月 | 67% | +1.2% | 3 |
| May5月 | 100% | +7.8% | 3 |
| Jun6月 | 50% | +0.6% | 4 |
| Jul7月 | 75% | +3.4% | 4 |
| Aug8月 | 67% | +2.1% | 3 |
| Sep9月 | 0% | -4.1% | 3 |
| Oct10月 | 100% | +8.2% | 3 |
| Nov11月 | 100% | +10.0% | 3 |
| Dec12月 | 67% | 0.0% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。